Recent meta-analyses conclude that both the use of ACE inhibitors and ARBs are safe and do not increase the risk of SARS-CoV-2 infection, nor does it increase the severity of COVID-19 (need for intensive therapy, use of mechanical ventilation, and death) (Lee et al., 2022). Here, ACE is linked to COVID-19.